Pinnacle Wealth Planning Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.09M | Sell |
2,215
-13
| -0.6% | -$7.05K | 0.11% | 104 |
|
|
2025
Q4 | $1.29M | Buy |
2,228
+31
| +1% | +$17.5K | 0.13% | 85 |
|
|
2025
Q3 | $1.07M | Buy |
2,197
+96
| +5% | +$44.7K | 0.12% | 96 |
|
|
2025
Q2 | $852K | Buy |
2,101
+329
| +19% | +$138K | 0.11% | 110 |
|
|
2025
Q1 | $881K | Sell |
1,772
-16
| -0.9% | -$8.67K | 0.13% | 90 |
|
|
2024
Q4 | $930K | Sell |
1,788
-729
| -29% | -$401K | 0.14% | 88 |
|
|
2024
Q3 | $1.56M | Sell |
2,517
-72
| -3% | -$42.6K | 0.21% | 63 |
|
|
2024
Q2 | $1.43M | Sell |
2,589
-93
| -3% | -$53.3K | 0.2% | 68 |
|
|
2024
Q1 | $1.56M | Sell |
2,682
-255
| -9% | -$143K | 0.23% | 63 |
|
|
2023
Q4 | $1.56M | Buy |
2,937
+168
| +6% | +$81.3K | 0.24% | 62 |
|
|
2023
Q3 | $1.4M | Sell |
2,769
-358
| -11% | -$191K | 0.23% | 62 |
|
|
2023
Q2 | $1.63M | Sell |
3,127
-160
| -5% | -$86.3K | 0.26% | 56 |
|
|
2023
Q1 | $1.89M | Sell |
3,287
-88
| -3% | -$49.6K | 0.31% | 51 |
|
|
2022
Q4 | $1.86M | Sell |
3,375
-155
| -4% | -$82.1K | 0.33% | 53 |
|
|
2022
Q3 | $1.79M | Buy |
3,530
+285
| +9% | +$159K | 0.33% | 52 |
|
|
2022
Q2 | $1.76M | Buy |
3,245
+373
| +13% | +$205K | 0.32% | 55 |
|
|
2022
Q1 | $1.7M | Sell |
2,872
-104
| -3% | -$59.7K | 0.31% | 58 |
|
|
2021
Q4 | $1.99M | Buy |
2,976
+74
| +3% | +$46.2K | 0.39% | 50 |
|
|
2021
Q3 | $1.66M | Buy |
2,902
+164
| +6% | +$90K | 0.37% | 55 |
|
|
2021
Q2 | $1.38M | Buy |
2,738
+22
| +0.8% | +$10.4K | 0.32% | 61 |
|
|
2021
Q1 | $1.24M | Sell |
2,716
-40
| -1% | -$19.1K | 0.32% | 61 |
|
|
2020
Q4 | $1.28M | Sell |
2,756
-15
| -0.5% | -$7.03K | 0.31% | 53 |
|
|
2020
Q3 | $1.22M | Sell |
2,771
-142
| -5% | -$58.7K | 0.4% | 44 |
|
|
2020
Q2 | $1.05M | Buy |
2,913
+81
| +3% | +$27.1K | 0.34% | 56 |
|
|
2020
Q1 | $802K | Buy |
2,832
+533
| +23% | +$168K | 0.38% | 54 |
|
|
2019
Q4 | $746K | Buy |
2,299
+378
| +20% | +$115K | 0.35% | 64 |
|
|
2019
Q3 | $559K | Sell |
1,921
-26
| -1% | -$7.45K | 0.3% | 71 |
|
|
2019
Q2 | $572K | Buy |
1,947
+85
| +5% | +$23.4K | 0.35% | 58 |
|
|
2019
Q1 | $510K | Sell |
1,862
-149
| -7% | -$37.1K | 0.34% | 59 |
|
|
2018
Q4 | $450K | Sell |
2,011
-39
| -2% | -$9.15K | 0.29% | 73 |
|
|
2018
Q3 | $500K | Buy |
2,050
+191
| +10% | +$43.9K | 0.46% | 71 |
|
|
2018
Q2 | $385K | Sell |
1,859
-176
| -9% | -$37.4K | 0.37% | 91 |
|
|
2018
Q1 | $419K | Buy |
2,035
+1,584
| +351% | +$332K | 0.43% | 79 |
|
|
2017
Q4 | $85K | Buy |
+451
| New | +$86.4K | 0.17% | 98 |
|
Other funds holding TMO
VCM
Pinnacle Wealth Planning Services's TMO Position: Q1 2026 in Review
Pinnacle Wealth Planning Services reduced its Thermo Fisher Scientific (TMO) stake by 0.58% in Q1 2026, selling an estimated $7.05K and leaving 2,215 shares worth $1.09M. The position accounts for 0.11% of the portfolio, ranked #104.
Pinnacle Wealth Planning Services first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.99M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Pinnacle Wealth Planning Services held 2,215 shares of Thermo Fisher Scientific worth $1.09M as of Q1 2026.
- Pinnacle Wealth Planning Services sold 13 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.05K.
- Thermo Fisher Scientific made up 0.11% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #104 holding.
- Pinnacle Wealth Planning Services first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
- Pinnacle Wealth Planning Services's Thermo Fisher Scientific position peaked at $1.99M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.